PETMED EXPRESS INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against PetMed Express, Inc. for possible violations of federal securities laws and unlawful business practices [1][2] Investigation Details - The investigation is focused on whether PetMed has engaged in any unlawful activities that may have affected its stockholders [1][2] - Investors who have suffered losses and are long-term stockholders are encouraged to reach out for more information regarding their rights [3] Company Background - Bragar Eagel & Squire, P.C. is a law firm that represents individual and institutional investors in various types of litigation across the United States [4] - The firm has offices in New York and California and specializes in commercial and securities litigation [4] Recent Developments - On June 10, 2025, PetMed announced a delay in releasing its fourth quarter and fiscal year 2025 earnings due to the need for additional time to complete the year-end audit [6] - Following this announcement, PetMed's stock price dropped by $0.47, or 11.22%, closing at $3.72 per share on June 11, 2025 [6]